Mark Talamonti MD

Mark S. Talamonti, M.D. is Professor of Surgery at the University of Chicago Pritzker School of Medicine and Chairman of the Department of Surgery at NorthShore University HealthSystem. Dr. Talamonti received his undergraduate education at John Carroll University in Cleveland, Ohio. Following graduation from Northwestern University Medical School in 1983, Dr. Talamonti completed a residency in General Surgery at Northwestern and then fellowship in Surgical Oncology at MD Anderson Cancer Center. Dr. Talamonti spent the next 16 years at Northwestern as Director of the Gastrointestinal Oncology Program, Chief of Surgical Oncology, and Professor of Surgery. In 2007, Dr. Talamonti moved to NorthShore University HealthSystem as Chairman of Surgery. Dr. Talamonti’s clinical expertise focuses on the area of gastrointestinal surgical oncology with specific interests in pancreas and liver cancers. Dr. Talamonti has served as the principal investigator on two Intergroup Trials examining the role of chemoradiation as neoadjuvant strategies prior to resection for potentially resectable and borderline resectable pancreatic cancers. Dr. Talamonti is the author of over 175 peer-reviewed scientific publications and 30 book chapters. He has authored two books on Liver Surgery and Gastrointestinal Oncology. He has also served on the Editorial Board for the Annals of Surgical Oncology and the Journal of Surgical Oncology. Dr. Talamonti has been the Chairman for the Medical Advisory Board for the Pancreatic Cancer Action Network (PanCAN) and the Committee for the Pancreatic Cancer Guidelines of the National Comprehensive Cancer Center Network (NCCN). Dr. Talamonti also served as the President of the Chicago Surgical Association for 2015-2016 and President of the Western Surgical Association for 2018. As Chairman at NorthShore, he leads a multi-faceted department which is clinically one of the most critical programs in a nationally recognized regional health system with over 900 employed physicians, four hospitals and 75 practice-entry sites.